Cargando…

P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE

Detalles Bibliográficos
Autores principales: Mascarenhas, J., Gerds, A. T., Kish, J. K., Abraham, P., Balanean, A., Nadal, J. A., Liassou, D., Feinberg, B. A., McBride, A., Harrison, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431234/
http://dx.doi.org/10.1097/01.HS9.0000847108.51760.ea
_version_ 1784779996636643328
author Mascarenhas, J.
Gerds, A. T.
Kish, J. K.
Abraham, P.
Balanean, A.
Nadal, J. A.
Liassou, D.
Feinberg, B. A.
McBride, A.
Harrison, C.
author_facet Mascarenhas, J.
Gerds, A. T.
Kish, J. K.
Abraham, P.
Balanean, A.
Nadal, J. A.
Liassou, D.
Feinberg, B. A.
McBride, A.
Harrison, C.
author_sort Mascarenhas, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9431234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94312342022-08-31 P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE Mascarenhas, J. Gerds, A. T. Kish, J. K. Abraham, P. Balanean, A. Nadal, J. A. Liassou, D. Feinberg, B. A. McBride, A. Harrison, C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431234/ http://dx.doi.org/10.1097/01.HS9.0000847108.51760.ea Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Mascarenhas, J.
Gerds, A. T.
Kish, J. K.
Abraham, P.
Balanean, A.
Nadal, J. A.
Liassou, D.
Feinberg, B. A.
McBride, A.
Harrison, C.
P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title_full P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title_fullStr P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title_full_unstemmed P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title_short P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
title_sort p1060: real-world clinical outcomes after 3 and 6 months of treatment with fedratinib following ruxolitinib failure
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431234/
http://dx.doi.org/10.1097/01.HS9.0000847108.51760.ea
work_keys_str_mv AT mascarenhasj p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT gerdsat p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT kishjk p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT abrahamp p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT balaneana p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT nadalja p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT liassoud p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT feinbergba p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT mcbridea p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure
AT harrisonc p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure